Olmesartan medoxomil China Market Insight
3 items
-
Zhejiang Tianyu Pharmaceutical Co., Ltd. olmesartan medoxomil new version GMP inspection announcement
-
Olmsartan Intermediate' regained No. 1 in sales after the new plant of Huanggang Luban Pharmaceutical was put into production
-
Luban Pharmaceutical has a net profit of 17.59 million yuan in 2020, and the production of olmesartan and other raw materials and intermediates increases
Breaking News
-
[Urea]: International Urea Price Closing Week (20260926)
Sep 26 -
Urea Weekly Report (September 14, 2026 - September 20, 2026)
Sep 22 -
[Polyamide 6]: September 21, 2026 East China market price of polyamide 6
Sep 21 -
[EVA]: Thailand TPI EVA – New USD Quote Flash Update (2026-09-21)
Sep 21 -
Urea Weekly Report (September 21, 2026 - September 27, 2026)
Sep 28 -
Jiangsu Suope Acetic Acid Price Flash Report (2026-09-28)
Sep 28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)